Mexico - Hospital Average Length of Stay for Hyperplasia of Prostate
Since 2014, Mexico Hospital Average Length of Stay for Hyperplasia of Prostate decreased by 4.9% year on year. At 2.8 Days in 2019, the country was ranked number 24 comparing other countries in Hospital Average Length of Stay for Hyperplasia of Prostate. Mexico is overtaken by New Zealand, which was number 23 with 3.1 Days and is followed by Finland at 2.6 Days. Lithuania topped the ranking with 6.1 Days in 2019, that is -1.6% versus 2018. Slovenia witnessed the best average annual growth at +4.6% per year, while Netherlands witnessed the worst performance at -6.8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 2.80 |
| 2018 | 2.90 |
| 2017 | 2.90 |
| 2016 | 2.80 |
| 2015 | 3.60 |
Download all data from 1995 to 2019
How does Mexico rank in Hospital Average Length of Stay for Hyperplasia of Prostate?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Lithuania
|
6.10 | 2019 | -1.6 % | -1.0 % | View data | |
| 1 |
#1
South Korea
|
6.10 | 2019 | -1.6 % | -1.0 % | View data | |
| 23 |
#23
New Zealand
|
3.10 | 2019 | +0.0 % | -0.6 % | View data | |
| 24 |
#24
Mexico
|
2.80 | 2019 | -3.5 % | -4.9 % | View data | |
| 25 |
#25
Finland
|
2.60 | 2019 | -3.7 % | -3.5 % | View data | |